Michael Scolaro

Michael Scolaro

Oct 07, 2017

Group 6 Copy 215
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can low carbohydrate ketogenic diets inhibit cancers?

Insulin is a hormone which supports growth of normal cells, but also of cancers. A very low carbohydrate (VLC...

What can we do to improve survival in babies with respiratory distress in Bangladesh?

Respiratory Distress is a treatable disease which kills hundreds of thousands of babies every year. Most of...

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

Backer Badge Funded